Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

NCT05873322 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT05873322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05873322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 30, 2022
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-induced diabetes mellitus, impaired glucose tolerance, lymphoma, precursor cell lymphoblastic leukemia-lymphoma